高收入地区确诊糖尿病患者全因死亡率趋势:多国汇总数据分析
19个数据源中17个糖尿病患者年龄和性别标化死亡率下降,年变化从匈牙利-0.5%到香港-4.2%;8个数据源糖尿病患者死亡率下降快于非糖尿病患者。
要点
- 19个数据源中17个糖尿病患者标化死亡率下降,年变化从匈牙利-0.5%到香港-4.2%。
- 19个数据源中8个糖尿病患者死亡率下降快于非糖尿病患者。
- 糖尿病患者与非糖尿病患者标化死亡率比值年变化从美国Medicare的-3.0%到意大利Lombardy的1.6%。
核心结论
- 在评估的大多数高收入国家中,糖尿病患者的全因死亡率已下降。
- 在分析的19个数据源中,有8个数据源糖尿病患者死亡率下降快于非糖尿病患者。
- 要进一步延长寿命,需要持续改善糖尿病的预防和管理。
研究设计与样本
- 回顾性多国汇总数据分析,收集16个高收入国家或地区19个数据源的数据。
- 数据来源包括行政数据、健康保险记录、登记系统和一项健康调查。
- 研究时段为1995年1月1日至2016年12月31日(或其中部分时段)。
- 研究对象为确诊总糖尿病或2型糖尿病的患者,采用标准化死亡率比(SMR)估计超额死亡率。
主要发现
- 19个数据源中17个显示糖尿病患者年龄和性别标化死亡率下降,年百分比变化从匈牙利-0.5%(95%CI -0.7至-0.3)到香港-4.2%(95%CI -4.3至-4.1)。
- 死亡率下降最大见于东亚和东南亚:香港-4.2%(95%CI -4.3至-4.1)、韩国-4.0%(95%CI -4.8至-3.2)、台湾-3.5%(95%CI -4.0至-3.0)、新加坡-3.6%(95%CI -4.2至-2.9)。
- 糖尿病患者与非糖尿病患者之间SMR的年估计变化从-3.0%(95%CI -3.0至-2.9;美国Medicare)到1.6%(95%CI 1.4至1.7;意大利Lombardy)。
- 在糖尿病患者死亡率下降的17个数据源中,5个数据源SMR显著增加,4个数据源SMR无显著变化,8个数据源SMR显著下降。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Population-level trends in mortality among people with diabetes are inadequately described. We aimed to examine the magnitude and trends in excess all-cause mortality in people with diabetes. METHODS: In this retrospective, multicountry analysis, we collected aggregate data from 19 data sources in 16 high-income countries or jurisdictions (in six data sources in Asia, eight in Europe, one from Australia, and four from North America) for the period from Jan 1, 1995, to Dec 31, 2016, (or a subset of this period) on all-cause mortality in people with diagnosed total or type 2 diabetes. We collected data from administrative sources, health insurance records, registries, and a health survey. We estimated excess mortality using the standardised mortality ratio (SMR). FINDINGS: In our dataset, there were approximately 21 million deaths during 0·5 billion person-years of follow-up among people with diagnosed diabetes. 17 of 19 data sources showed decreases in the age-standardised and sex-standardised mortality in people with diabetes, among which the annual percentage change in mortality ranged from -0·5% (95% CI -0·7 to -0·3) in Hungary to -4·2% (-4·3 to -4·1) in Hong Kong. The largest decreases in mortality were observed in east and southeast Asia, with a change of -4·2% (95% CI -4·3 to -4·1) in Hong Kong, -4·0% (-4·8 to -3·2) in South Korea, -3·5% (-4·0 to -3·0) in Taiwan, and -3·6% (-4·2 to -2·9) in Singapore. The annual estimated change in SMR between people with and without diabetes ranged from -3·0% (95% CI -3·0 to -2·9; US Medicare) to 1·6% (1·4 to 1·7; Lombardy, Italy). Among the 17 data sources with decreasing mortality among people with diabetes, we found a significant SMR increase in five data sources, no significant SMR change in four data sources, and a significant SMR decrease in eight data sources. INTERPRETATION: All-cause mortality in diabetes has decreased in most of the high-income countries we assessed. In eight of 19 data sources analysed, mortality decreased more rapidly in people with diabetes than in those without diabetes. Further longevity gains will require continued improvement in prevention and management of diabetes. FUNDING: US Centers for Disease Control and Prevention, Diabetes Australia Research Program, and Victoria State Government Operational Infrastructure Support Program.
引用
- Magliano DJ, Chen L, Carstensen B, et al. Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data. Lancet Diabetes Endocrinol. 2022. PMID: 35026157. doi:10.1016/S2213-8587(21)00327-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。